انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
Simon Baunwall on faecal microbiota transplantation for first or second Clostridioides difficile infection
Manage episode 346589168 series 2891295
Simon Baunwall (Aarhus University Hospital) discusses the EarlyFMT trial, a randomized placebo-controlled trial of faecal microbiota transplantation for first or second Clostridioides difficile infection.
Read the full article:
Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT)
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
84 حلقات
Simon Baunwall on faecal microbiota transplantation for first or second Clostridioides difficile infection
The Lancet Gastroenterology & Hepatology in conversation with
Manage episode 346589168 series 2891295
Simon Baunwall (Aarhus University Hospital) discusses the EarlyFMT trial, a randomized placebo-controlled trial of faecal microbiota transplantation for first or second Clostridioides difficile infection.
Read the full article:
Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT)
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
84 حلقات
كل الحلقات
×
1 Hannes Hagström on screening for advanced liver fibrosis alongside retina scanning in people with type 2 diabetes 21:23

1 Cathy Lu on intestinal ultrasound for assessing and monitoring Crohn's disease small bowel strictures 11:15

1 Peter De Cruz on the PREDICT-UC trial of intensified versus standard dose infliximab for steroid-refractory acute severe ulcerative colitis 14:42

1 Shahida Din and Beatriz Gros on the harms associated with receiving placebo in trials of drugs for inflammatory bowel disease 34:15

1 Arndt Vogel on the NALIRICC trial of nanoliposomal irinotecan in pretreated advanced biliary tract cancer 18:23

1 Nancy Baxter on the duration of colorectal cancer risk reduction with a complete colonoscopy 25:05

1 Sanna Nybacka and Magnus Simrén on a trial of low FODMAP diets versus low carbohydrate diets in IBS 23:16

1 Nuru Noor on the PROFILE trial of biomarker-stratified treatment in newly diagnosed Crohn's disease 19:55

1 Yusuke Shimakawa on a simple score for hepatitis B treatment eligibility in Africa 20:54

1 Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake 16:39

1 Louise Dye on the role of expectancy and gluten in non-coeliac gluten sensitivity 23:19

1 Tzu-Chan Hong on the primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region 14:40

1 Sarah Moen on metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after colectomy 14:45

1 Anna Emilie Kann on the causes of mortality in patients with alcohol-related liver disease 16:19

1 Robert Krouse on surgical versus non-surgical management of malignant bowel obstruction 16:31
مرحبًا بك في مشغل أف ام!
يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.